No title
Neuroblastoma is an embryonal malignancy that accounts for 15% of all cancer related deaths amongst children. Although the overall survival of patients has been improving over the last decades, the high-risk neuroblastoma patients have a survival rate of <50%. Using gene expression microarrays we identify a group of proteins (snoRNPs) whose expression correlates with poor prognosis. We futher show
